iTeos Therapeutics, Inc. - Common Stock, par value $0.001 per share (ITOS)

Historical Holders from Q3 2020 to Q1 2025

Symbol
ITOS on Nasdaq
CUSIP
46565G104
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
37M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
34.1M
Holdings value
$262M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
133
Number of buys
69
Number of sells
-81
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of iTeos Therapeutics, Inc. - Common Stock, par value $0.001 per share (ITOS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock Portfolio Management LLC 6.1% $13.9M 2.33M BlackRock Portfolio Management LLC Mar 31, 2025
TANG CAPITAL MANAGEMENT LLC 0.6% $1.32M 222K TANG CAPITAL MANAGEMENT, LLC Dec 31, 2024

Institutional Holders of iTeos Therapeutics, Inc. - Common Stock, par value $0.001 per share (ITOS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 76.3K $456K -$91.5K $5.97 6
2024 Q4 34.1M $262M -$45.4M $7.68 133
2024 Q3 36.6M $373M -$1.63M $10.21 146
2024 Q2 36.2M $537M +$29.4M $14.84 132
2024 Q1 34.2M $466M -$7.32M $13.64 126
2023 Q4 35M $383M -$15.7M $10.95 130
2023 Q3 35.5M $389M +$6.64M $10.95 141
2023 Q2 34.5M $457M -$19.2M $13.24 140
2023 Q1 36M $489M -$8.81M $13.61 149
2022 Q4 36.2M $707M -$15.8M $19.53 144
2022 Q3 35.6M $677M -$16.1M $19.05 131
2022 Q2 35.3M $723M -$10.9M $20.60 143
2022 Q1 35.1M $1.13B +$60.2M $32.18 149
2021 Q4 32.6M $1.52B +$93.9M $46.56 113
2021 Q3 31M $837M +$54M $27.00 75
2021 Q2 29.4M $753M -$19.7M $25.65 81
2021 Q1 30.1M $1.03B +$90.2M $34.18 75
2020 Q4 25.8M $870M +$60.3M $33.82 69
2020 Q3 24.5M $604M +$546M $24.67 53